These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15063355)

  • 1. Inflammatory markers and coronary artery disease.
    Fichtlscherer S; Heeschen C; Zeiher AM
    Curr Opin Pharmacol; 2004 Apr; 4(2):124-31. PubMed ID: 15063355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].
    Trepels T; Zeiher AM; Fichtlscherer S
    Herz; 2004 Dec; 29(8):769-76. PubMed ID: 15599673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Markers of inflammatory process in stable and unstable coronary artery disease].
    Okopień B; Basiak M; Madej A; Labuzek K; Belowski D; Haberka M; Herman ZS
    Pol Merkur Lekarski; 2006 Jul; 21(121):69-72. PubMed ID: 17007298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.
    Heeschen C; Dimmeler S; Hamm CW; Fichtlscherer S; Simoons ML; Zeiher AM;
    J Am Coll Cardiol; 2005 Jan; 45(2):229-37. PubMed ID: 15653020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pro-inflammatory and anti-inflammatory markers in coronary artery disease and acute ischemic coronary syndrome].
    Fragoso-Lona JM; Ramírez-Bello J; Cruz-Robles D; Pérez-Méndez O; de la Peña A; Vargas-Alarcón G
    Arch Cardiol Mex; 2009; 79(1):54-62. PubMed ID: 19545076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-traditional biomarkers of atherosclerosis in stable and unstable coronary artery disease, do they differ?
    Konstantino Y; Wolk R; Terra SG; Nguyen TT; Fryburg DA
    Acute Card Care; 2007; 9(4):197-206. PubMed ID: 17924231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory biomarkers in stable atherosclerosis.
    Kinlay S; Egido J
    Am J Cardiol; 2006 Dec; 98(11A):2P-8P. PubMed ID: 17126676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inflammation markers in acute coronary syndrome].
    Mirat J; Raguz M; Romić Z; Bergovec M; Raos V; Sikić-Vagić J; Bergovec M
    Acta Med Croatica; 2004; 58(2):115-7. PubMed ID: 15208795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory biomarkers of coronary atheromatous plaque vulnerability.
    Avanzas P; Arroyo-Espliguero R; Garcia-Moll X; Kaski JC
    Panminerva Med; 2005 Jun; 47(2):81-91. PubMed ID: 16210993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity C-reactive protein may be an indicator of the development of atherosclerosis in myocardial bridging.
    Duygu H; Zoghi M; Nalbantgil S; Ozerkan F; Cakir C; Ertas F; Yuksek U; Akilli A; Akin M; Ergene O
    Int J Cardiol; 2008 Feb; 124(2):267-70. PubMed ID: 17395309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of low-grade inflammation and soluble cell adhesion molecules in Chinese patients with coronary artery disease.
    Fang L; Wei H; Mak KH; Xiong Z; Song J; Wang D; Lim YL; Chatterjee S
    Can J Cardiol; 2004 Dec; 20(14):1433-8. PubMed ID: 15614337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory markers: linking unstable plaques to coronary event, an interventional perspective.
    Aronson D
    Int J Cardiovasc Intervent; 2004; 6(3-4):110-8. PubMed ID: 16146903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
    Koenig W
    Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation, atherosclerosis, and stroke.
    Elkind MS
    Neurologist; 2006 May; 12(3):140-8. PubMed ID: 16688015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
    Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
    Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of inflammation and coronary artery disease.
    Saadeddin SM; Habbab MA; Ferns GA
    Med Sci Monit; 2002 Jan; 8(1):RA5-12. PubMed ID: 11782689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of atherosclerotic indicators between cardio ankle vascular index and brachial ankle pulse wave velocity.
    Horinaka S; Yabe A; Yagi H; Ishimura K; Hara H; Iemua T; Matsuoka H
    Angiology; 2009; 60(4):468-76. PubMed ID: 19015165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina.
    Miyamoto S; Ueda M; Ikemoto M; Naruko T; Itoh A; Tamaki S; Nohara R; Terasaki F; Sasayama S; Fujita M
    Heart; 2008 Aug; 94(8):1002-7. PubMed ID: 18308864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.